The oncogenic role of Yin Yang

Critical Reviews in Oncogenesis

Volumn 16, Issue 3-4, 2011, Pages 163-197

  Zhang, Qiang ^a   Stovall, Daniel B ^a   Inoue, Kazushi ^a   Sui, Guangchao ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Oncogene; Protein modifcation; Transcription factor; Tumorigenesis; Yin yang 1

Indexed keywords

DNA; TRANSCRIPTION FACTOR YY1;

ACETYLATION; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA DAMAGE; EDITORIAL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; METHYLATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; SUMOYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSCRIPTION REPRESSION;

EID: 84862908104     PISSN: 08939675     EISSN: 21626448     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v16.i3-4.30     Document Type: Editorial

References (254)

1. Shi Y, Seto E, Chang LS, Shenk T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 1991;67(2):377-388.
2. Seto E, Shi Y, Shenk T. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature. 1991;354(6350):241-245.
3. Park K, Atchison ML. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci U S A. 1991;88(21):9804-9808.
4. Hariharan N, Kelley DE, Perry RP. Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc fnger protein. Proc Natl Acad Sci U S A. 1991;88(21):9799-97803.
5. Flanagan JR, Becker KG, Ennist DL, Gleason SL, Driggers PH, Levi BZ, et al. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol. 1992;12(1):38-44.
6. Tomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene. 1999;236(2):197-208.
7. Hyde-DeRuyscher RP, Jennings E, Shenk T. DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res. 1995;23(21):4457-4465.
8. Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta. 1997;1332(2):F49-F66.
9. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Onco-gene. 2006;25(8):1125-1142.
10. Sui G. Te regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy. Mol Cell Pharmacol. 2009;1(3):157-176.
11. Deng Z, Cao P, Wan M, Sui G. Yin Yang 1: a multifaceted protein beyond a transcription factor. Transcription. 2010;1(2):81-84.
12. Yant SR, Zhu W, Millinof D, Slightom JL, Goodman M, Gumucio DL. High afnity YY1 binding motifs: identifcation of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster. Nucleic Acids Res. 1995;23(21):4353-4362.
13. Kim J, Kim J. YY1's longer DNA-binding motifs. Genomics. 2009;93(2):152-158.
14. Riggs KJ, Saleque S, Wong KK, Merrell KT, Lee JS, Shi Y, et al. Yin-yang 1 activates the c-myc promoter. Mol Cell Biol. 1993;13(12):7487-7495.
15. Rezai-Zadeh N, Zhang X, Namour F, Fejer G, Wen YD, Yao YL, et al. Targeted recruitment of a histone H4-specifc methyltransferase by the transcription factor YY1. Genes Dev. 2003;17(8):1019-1029.
16. Faiola F, Liu X, Lo S, Pan S, Zhang K, Lymar E, et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol Cell Biol. 2005;25(23):10220-10234.
17. Sankar N, Baluchamy S, Kadeppagari RK, Sin-ghal G, Weitzman S, Timmapaya B. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene. 2008;27(43):5717-5728.
18. Kadeppagari RK, Sankar N, Timmapaya B. Ade-novirus transforming protein E1A induces c-Myc in quiescent cells by a novel mechanism. J Virol. 2009;83(10):4810-4822.
19. Hu HM, Kanda K, Zhang L, Boxer LM. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer. Leukemia. 2007;21(4):747-753.
20. Zhou Q, Gedrich RW, Engel DA. Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J Virol. 1995;69(7):4323-4330.
21. Zhou Q, Engel DA. Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter. J Virol. 1995;69(12):7402-7409.
22. Natesan S, Gilman M. YY1 facilitates the association of serum response factor with the c-fos serum response element. Mol Cell Biol. 1995;15(11):5975-5982.
23. Chang PJ, Chen LW, Shih YC, Tsai PH, Liu AC, Hung CH, et al. Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus. Virology. 2011;413(2):194-204.
24. Mai RT, Yeh TS, Kao CF, Sun SK, Huang HH, Wu Lee YH. Hepatitis C virus core protein recruits nucleolar phosphoprotein B23 and coactivator p300 to relieve the repression efect of transcriptional factor YY1 on B23 gene expression. Oncogene. 2006;25(3):448-462.
25. Ye K. Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis. Cancer Biol Ter. 2005;4(9):918-923.
26. Inouye CJ, Seto E. Relief of YY1-induced transcrip-tional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem. 1994;269(9):6506-6510.
27. Weng JJ, Yung BY. Nucleophosmin/B23 regulates PCNA promoter through YY1. Biochem Biophys Res Commun. 2005;335(3):826-831.
28. Sharif N, Farrar WL. Androgen receptor as a therapeutic target for androgen independent prostate cancer. Am J Ter. 2006;13(2):166-170.
29. Deng Z, Wan M, Cao P, Rao A, Cramer SD, Sui G. Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene. 2009;28(42):3746-3757.
30. Begon DY, Delacroix L, Vernimmen D, Jack-ers P, Winkler R. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J Biol Chem. 2005;280(26):24428-24434.
31. Allouche A, Nolens G, Tancredi A, Delacroix L, Mardaga J, Fridman V, et al. Te combined immunode-tection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Res. 2008;10(1):R9.
32. Harari D, Yarden Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. 2000;19(53):6102-6114.
33. Seshadri R, Matthews C, Dobrovic A, Horsfall DJ. Te signifcance of oncogene amplifcation in primary breast cancer. Int J Cancer. 1989;43(2):270-2.
34. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007;67(8):3496-9.
35. Baumeister P, Luo S, Skarnes WC, Sui G, Seto E, Shi Y, et al. Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifers. Mol Cell Biol. 2005;25(11):4529-4540.
36. Mao C, Tai WC, Bai Y, Poizat C, Lee AS. In vivo regulation of Grp78/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4. J Biol Chem. 2006;281(13):8877-8887.
37. de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, et al. CXCR4/YY1 inhibition impairs VEGF network and angiogen-esis during malignancy. Proc Natl Acad Sci U S A. 2010;107(32):14484-14489.
38. Joo M, Wright JG, Hu NN, Sadikot RT, Park GY, Blackwell TS, et al. Yin Yang 1 enhances cyclooxyge-nase-2 gene expression in macrophages. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1219-L1226.
39. Takasaki N, Kurokawa D, Nakayama R, Nakayama J, Aizawa S. Acetylated YY1 regulates Otx2 expression in anterior neuroectoderm at two cis-sites 90 kb apart. EMBO J. 2007;26(6):1649-1659.
40. Palmer MB, Majumder P, Cooper JC, Yoon H, Wade PA, Boss JM. Yin Yang 1 regulates the expression of Snail through a distal enhancer. Mol Cancer Res. 2009;7(2):221-229.
41. Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, Liu YH, et al. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene. 2011. [Epub ahead of print]
42. Bonavida B, Baritaki S. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-kappaB/Snail/YY1/ RKIP circuitry. Nitric Oxide. 2011;24(1):1-7.
43. Tan DP, Nonaka K, Nuckolls GH, Liu YH, Maxson RE, Slavkin HC, et al. YY1 activates Msx2 gene independent of bone morphogenetic protein signaling. Nucleic Acids Res. 2002;30(5):1213-1223.
44. Ratajewski M, Pulaski L. YY1-dependent tran-scriptional regulation of the human GDAP1 gene. Genomics. 2009;94(6):407-413.
45. Zaravinos A, Lambrou GI, Boulalas I, Delakas D, Spandidos DA. Identifcation of common difer-entially expressed genes in urinary bladder cancer. PLoS ONE. 2011;6(4):e18135.
46. Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol. 2011;224(4):484-495.
47. Sui G, Afarel B, Shi Y, Brignone C, Wall NR, Yin P, et al. Yin Yang 1 is a negative regulator of p53. Cell. 2004;117(7):859-872.
48. Gronroos E, Terentiev AA, Punga T, Ericsson J. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci U S A. 2004;101(33):12165-12170.
49. Yakovleva T, Kolesnikova L, Vukojevic V, Gileva I, Tan-No K, Austen M, et al. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Biochem Biophys Res Commun. 2004;318(2):615-624.
50. Bain M, Sinclair J. Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death. Eur J Cell Biol. 2005;84(5):543-553.
51. Caggia S, Libra M, Malaponte G, Cardile V. Modulation of YY1 and p53 expression by transforming growth factor-beta3 in prostate cell lines. Cytokine. 2011. Epub 2011 July 31.
52. He G, Wang Q, Zhou Y, Wu X, Wang L, Duru N, et al. YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide. Int J Gynecol Cancer. 2011;21(6):1097-1104.
53. Furlong EE, Rein T, Martin F. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol Cell Biol. 1996;16(10):5933-45.
54. Wu S, Murai S, Kataoka K, Miyagishi M. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1. Biochem Biophys Res Commun. 2008;365(1):75-81.
55. Wang CC, Tsai MF, Dai TH, Hong TM, Chan WK, Chen JJ, et al. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. Cancer Res. 2007;67(10):4816-4826.
56. Zhang L, Cai X, Chen K, Wang Z, Wang L, Ren M, et al. Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells. Virus Res. 2011;157(1):76-81.
57. Lee MH, Lahusen T, Wang RH, Xiao C, Xu X, Hwang YS, et al. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation. Oncogene. 2011. [Epub ahead of print].
58. Eliassen KA, Baldwin A, Sikorski EM, Hurt MM. Role for a YY1-binding element in replication-dependent mouse histone gene expression. Mol Cell Biol. 1998;18(12):7106-7118.
59. Last TJ, van Wijnen AJ, Birnbaum MJ, Stein GS, Stein JL. Multiple interactions of the transcription factor YY1 with human histone H4 gene regulatory elements. J Cell Biochem. 1999;72(4):507-516.
60. Cunningham JT, Rodgers J T, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature. 2007;450(7170):736-740.
61. Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G, et al. Teubiquitin carboxyl hydro-lase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol. 2010;30(21):5071-5085.
62. Ko CY, Hsu HC, Shen MR, Chang WC, Wang JM. Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/ DNA methyltransferase complex. J Biol Chem. 2008;283(45):30919-30932.
63. Delehouzee S, Yoshikawa T, Sawa C, Sawada J, Ito T, Omori M, et al. GABP, HCF-1 and YY1 are involved in Rb gene expression during myogenesis. Genes Cells. 2005;10(7):717-731.
64. Wang X, Feng Y, Xu L, Chen Y, Zhang Y, Su D, et al. YY1 restrained cell senescence through repressing the transcription of p16. Biochim Biophys Acta. 2008;1783(10):1876-1883.
65. Santiago FS, Ishii H, Shaf S, Khurana R, Kanel-lakis P, Bhindi R, et al. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. Circ Res. 2007;101(2):146-155.
66. Mueller JK, Dietzel A, Lomniczi A, Loche A, Tefs K, Kiess W, et al. Transcriptional regulation of the human KiSS1 gene. Mol Cell Endocrinol. 2011;342(1-2):8-19.
67. Aoyama T, Okamoto T, Fukiage K, Otsuka S, Furu M, Ito K, et al. Histone modifers, YY1 and p300, regulate the expression of cartilage-specifc gene, chondromodulin-I, in mesenchymal stem cells. J Biol Chem. 2010;285(39):29842-29850.
68. Mijatovic S, Maksimovic-Ivanic D, Mojic M, Timo-tijevic G, Miljkovic D, Mangano K, et al. Cytotoxic and immune-sensitizing properties of nitric oxide-modifed Saquinavir in iNOS-positive human melanoma cells. J Cell Physiol. 2011;226(7):1803-1812.
69. Notarbartolo M, Giannitrapani L, Vivona N, Poma P, Labbozzetta M, Florena AM, et al. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. OMICS. 2011;15(5):267-72.
70. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyo-sarcoma. Cancer Cell. 2008;14(5):369-381.
71. Song G, Wang L. Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism. PLoS ONE. 2009;4(9):e6880.
72. Park SY, Lee JH, Ha M, Nam JW, Kim VN. MiR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 2009;16(1):23-29.
73. Wang X, Ling C, Bai Y, Zhao J. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec (Hoboken). 2011;294(1):88-92.
74. Zheng H, Chu J, Zeng Y, Loh HH, Law PY. Yin Yang 1 phosphorylation contributes to the diferential efects of mu-opioid receptor agonists on microRNA-190 expression. J Biol Chem. 2010;285(29):21994-22002.
75. Beezhold K, Liu J, Kan H, Meighan T, Castranova V, Shi X, et al. MiR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol Sci. 2011;123(2):411-420.
76. Palko L, Bass HW, Beyrouthy MJ, Hurt MM. The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase. J Cell Sci. 2004;117(Pt 3):465-476.
77. Rizkallah R, Hurt MM. Regulation of the transcription factor YY1 in mitosis through phosphoryla-tion of its DNA-binding domain. Mol Biol Cell. 2009;20(22):4766-4776.
78. Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E, et al. Relief of YY1 transcrip-tional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 1995;9(10):1188-1198.
79. Li M, Luo J, Brooks CL, Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem. 2002;277(52):50607-50611.
80. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W. Acetylation of p53 augments its site-specifc DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A. 2004;101(8):2259-2264.
81. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci U S A. 1996;93(23):12845-12850.
82. Luke MP, Sui G, Liu H, Shi Y. Yin Yang 1 physically interacts with HOXA11 and represses HOXA11-dependent transcription. J Biol Chem. 2006;281(44):33226-33232.
83. Ren G, Zhang G, Dong Z, Liu Z, Li L, Feng Y, et al. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to afect cell growth in AR-negative prostate cancers. Int J Biochem Cell Biol. 2009;41(5):1094-1101.
84. Wang L, Brown JL, Cao R, Zhang Y, Kas-sis JA, Jones RS. Hierarchical recruitment of polycomb group silencing complexes. Mol Cell. 2004;14(5):637-646.
85. Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. Te Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle diferentiation. Genes Dev. 2004;18(21):2627-2638.
86. Wilkinson FH, Park K, Atchison ML. Poly-comb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci U S A. 2006;103(51):19296-19301.
87. Wilkinson F, Pratt H, Atchison ML. PcG recruitment by the YY1 REPO domain can be mediated by Yaf2. J Cell Biochem. 2010;109(3):478-486.
88. Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V, et al. TNF/p38alpha/poly-comb signaling to Pax7 locus in satellite cells links infammation to the epigenetic control of muscle regeneration. Cell stem cell. 2010;7(4):455-469.
89. Cedar H, Bergman Y. Linking DNA methylation and histone modifcation: patterns and paradigms. Nat Rev Genet. 2009;10(5):295-304.
90. Afarel B, Gay F, Shi Y, Liu H, Huarte M, Wu S, et al. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol Cell Biol. 2006;26(9):3565-3581.
91. Seelan RS, Grossman LI. Structural organization and promoter analysis of the bovine cytochrome c oxidase subunit VIIc gene. A functional role for YY1. J Biol Chem. 1997;272(15):10175-10181.
92. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 2004;18(17):2046-2059.
93. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev. 2005;15(5):536-541.
94. Deng Z, Wan M, Sui G. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING fnger. Mol Cell Biol. 2007;27(10):3780-3792.
95. Xu J, De Zhu J, Ni M, Wan F, Gu JR. Te ATF/ CREB site is the key element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene. Cell Res. 2002;12(3-4):177-197.
96. Lu P, Hankel IL, Hostager BS, Swartzendruber JA, Friedman AD, Brenton JL, et al. Te developmental regulator protein Gon4l associates with protein YY1, co-repressor Sin3a, and histone deacetylase 1 and mediates transcriptional repression. J Biol Chem. 2011;286(20):18311-18319.
97. Petrella BL, Brinckerhof CE. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma. Cancer Biol Ter. 2009;8(14):1389-1401.
98. Taguchi S, Kawachi Y, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, et al. Overexpression of the transcription factor Yin-Yang-1 suppresses difer-entiation of HaCaT cells in three-dimensional cell culture. J Invest Dermatol. 2011;131(1):37-45.
99. Wu S, Hu YC, Liu H, Shi Y. Loss of YY1 impacts the heterochromatic state and meiotic double-strand breaks during mouse spermatogenesis. Mol Cell Biol. 2009;29(23):6245-6256.
100. Srinivasan L, Atchison ML. YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev. 2004;18(21):2596-2601.
101. Atchison L, Ghias A, Wilkinson F, Bonini N, Atchi-son ML. Transcription factor YY1 functions as a PcG protein in vivo. EMBO J. 2003;22(6):1347-13458.
102. Rylski M, Amborska R, Zybura K, Miodusze-wska B, Michaluk P, Jaworski J, et al. Yin Yang 1 is a critical repressor of matrix metalloprotei-nase-9 expression in brain neurons. J Biol Chem. 2008;283(50):35140-35153.
103. Basu A, Atchison ML. CtBP levels control intergenic transcripts, PHO/YY1 DNA binding, and PcG recruitment to DNA. J Cell Biochem. 2010;110(1):62-69.
104. Garcia E, Marcos-Gutierrez C, del Mar Lorente M, Moreno JC, Vidal M. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. EMBO J. 1999;18(12):3404-3418.
105. Schlisio S, Halperin T, Vidal M, Nevins JR. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specifcity of E2F function. EMBO J. 2002;21(21):5775-5786.
106. Chen D, Zhang J, Li M, Rayburn ER, Wang H, Zhang R. RYBP stabilizes p53 by modulating MDM2. EMBO Rep. 2009;10(2):166-172.
107. Huang NE, Lin CH, Lin YS, Yu WC. Modulation of YY1 activity by SAP30. Biochem Biophys Res Commun. 2003;306(1):267-575.
108. Le May N, Mansuroglu Z, Leger P, Josse T, Blot G, Billecocq A, et al. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS pathogens. 2008;4(1):e13.
109. Cai Y, Jin J, Yao T, Gottschalk AJ, Swanson SK, Wu S, et al. YY1 functions with INO80 to activate transcription. Nat Struct Mol Biol. 2007;14(9):872-874.
110. Wu S, Shi Y, Mulligan P, Gay F, Landry J, Liu H, et al. A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nat Struct Mol Biol. 2007;14(12):1165-1172.
111. Hiromura M, Choi CH, Sabourin NA, Jones H, Bachvarov D, Usheva A. YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcy-lation). J Biol Chem. 2003;278(16):14046-14052.
112. Gordon SJ, Saleque S, Birshtein BK. Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3' Igh enhancer, hs3. J Immunol. 2003;170(11):5549-5557.
113. Petkova V, Romanowski MJ, Sulijoadikusumo I, Rohne D, Kang P, Shenk T, et al. Interaction between YY1 and the retinoblastoma protein. Regulation of cell cycle progression in diferentiated cells. J Biol Chem. 2001;276(11):7932-7936.
114. Shrivastava A, Yu J, Artandi S, Calame K. YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc Natl Acad Sci U S A. 1996;93(20):10638-10641.
115. Vernon EG, Gaston K. Myc and YY1 mediate activation of the Surf-1 promoter in response to serum growth factors. Biochim Biophys Acta. 2000;1492(1):172-179.
116. Kang JH, Chang SY, Yeom DH, Kim SA, Um SJ, Hong KJ. Weakening of the repressive YY-1 site on the thrombospondin-1 promoter via c-Jun/YY-1 interaction. Exp Mol Med. 2004;36(4):300-310.
117. Krippner-Heidenreich A, Walsemann G, Bey-routhy MJ, Speckgens S, Kraft R, Tole H, et al. Caspase-Dependent Regulation and Sub-cellular Redistribution of the Transcriptional Modulator YY1 during Apoptosis. Mol Cell Biol. 2005;25(9):3704-3714.
118. Usheva A, Shenk T. YY1 transcriptional initiator: protein interactions and association with a DNA site containing unpaired strands. Proc Natl Acad Sci U S A. 1996;93(24):13571-13576.
119. Seto E, Lewis B, Shenk T. Interaction between transcription factors Sp1 and YY1. Nature. 1993;365(6445):462-464.
120. Austen M, Luscher B, Luscher-Firzlaf JM. Characterization of the transcriptional regulator YY1. Te bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J Biol Chem. 1997;272(3):1709-1717.
121. Renna M, Caporaso MG, Bonatti S, Kaufman RJ, Remondelli P. Regulation of ergic-53 gene transcription in response to endoplasmic reticulum stress. J Biol Chem. 2007;282(31):22499-22512.
122. Sakhinia E, Glennie C, Hoyland JA, Menasce LP, Brady G, Miller C, et al. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and difuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood. 2007;109(9):3922-3928.
123. Naidoo K, Clay V, Hoyland JA, Swindell R, Linton K, Illidge T, et al. YY1 expression predicts favourable outcome in follicular lymphoma. J Clin Pathol. 2011;64(2):125-129.
124. Kim JD, Yu S, Kim J. YY1 is autoregulated through its own DNA-binding sites. BMC Mol Biol. 2009;10:85.
125. Wang H, Hertlein E, Bakkar N, Sun H, Acharyya S, Wang J, et al. NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofbrillar genes. Mol Cell Biol. 2007;27(12):4374-4387.
126. Huerta-Yepez S, Vega M, Garban H, Bonavida B. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol. 2006;120(3):297-309.
127. Vega MI, Jazirehi AR, Huerta-Yepez S, Bonavida B. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappaB activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively. J Immunol. 2005;175(4):2174-2183.
128. Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA, Bonavida B. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol. 2007;179(8):5441-5453.
129. Joshi B, Rastogi S, Morris M, Carastro LM, DeCook C, Seto E, et al. Diferential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites. Biochem J. 2007;401(1):155-166.
130. Chinnappan D, Xiao D, Ratnasari A, Andry C, King TC, Weber HC. Transcription factor YY1 expression in human gastrointestinal cancer cells. Int J Oncol. 2009;34(5):1417-1423.
131. Safrany G, Perry RP. Characterization of the mouse gene that encodes the delta/YY1/NF-E1/UCRBP transcription factor. Proc Natl Acad Sci U S A. 1993;90(12):5559-5563.
132. Huang W, Smaldino PJ, Zhang Q, Miller LD, Cao P, Stadelman K, et al. Yin Yang 1 contains G-quadruplex structures in its promoter and 5'-UTR and its expression is modulated by G4 resolvase 1. Nucleic Acids Res. 2011 Oct 12. [Epub ahead of print].
133. Brooks TA, Kendrick S, Hurley L. Making sense of G-quadruplex and i-motif functions in oncogene promoters. FEBS J. 2010;277(17):3459-3469.
134. Vaughn JP, Creacy SD, Routh ED, Joyner-Butt C, Jenkins GS, Pauli S, et al. Te DEXH protein product of the DHX36 gene is the major source of tetramolecular quadruplex G4-DNA resolving activity in HeLa cell lysates. J Biol Chem. 2005;280(46):38117-38120.
135. Eddy J, Maizels N. Gene function correlates with potential for G4 DNA formation in the human genome. Nucleic Acids Res. 2006;34(14):3887-3896.
136. Becker KG, Jedlicka P, Templeton NS, Liotta L, Ozato K. Characterization of hUCRBP (YY1, NF-E1, delta): a transcription factor that binds the regulatory regions of many viral and cellular genes. Gene. 1994;150(2):259-266.
137. Rizkallah R, Alexander KE, Kassardjian A, Luscher B, Hurt MM. The transcription factor YY1 is a substrate for Polo-like kinase 1 at the G2/M transition of the cell cycle. PLoS ONE. 2011;6(1):e15928.
138. Yao YL, Yang WM, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol. 2001;21(17):5979-5991.
139. Jokela TA, Makkonen KM, Oikari S, Karna R, Koli E, Hart GW, et al. Cellular content of UDP-N-Acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-GlcNAc modifca-tion of transcription factors YY1 and SP1. J Biol Chem. 2011; 286(38):33632-33640.
140. Ozcan S, Andrali SS, Cantrell JE. Modulation of transcription factor function by O-GlcNAc modifcation. Biochim Biophys Acta. 2010;1799(5-6):353-364.
141. Griesenbeck J, Ziegler M, Tomilin N, Schweiger M, Oei SL. Stimulation of the catalytic activity of poly(ADP-ribosyl) transferase by transcription factor Yin Yang 1. FEBS Lett. 1999;443(1):20-4.
142. Oei SL, Shi Y. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem Biophys Res Commun. 2001;285(1):27-31.
143. Flanagan JR. Autologous stimulation of YY1 transcription factor expression: role of an insulin-like growth factor. Cell Growth Difer. 1995;6(2):185-190.
144. Huang HY, Li X, Liu M, Song TJ, He Q, Ma CG, et al. Transcription factor YY1 promotes adipogenesis via inhibiting CHOP-10 expression. Biochem Biophys Res Commun. 2008;375(4):496-500.
145. Yang H, Li TW, Peng J, Mato JM, Lu SC. Insulin-like growth factor 1 activates methionine adenosyltransferase 2A transcription by multiple pathways in human colon cancer cells. Biochem J. 2011;436(2):507-516.
146. Santiago FS, Lowe HC, Bobryshev YV, Khachigian LM. Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fbroblast growth factor-2. J Biol Chem. 2001;276(44):41143-41149.
147. Lin X, Sime PJ, Xu H, Williams MA, LaRussa L, Georas SN, et al. Yin Yang 1 is a novel regulator of pulmonary fbrosis. Am J Respir Crit Care Med. 2011;183(12):1689-1697.
148. Li H, Liu H, Wang Z, Liu X, Guo L, Huang L, et al. Te role of transcription factors Sp1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene in human lymphocytes. J Cell Biochem. 2008;104(1):237-250.
149. Hara Y, Kusumi Y, Mitsumata M, Li XK, Fujino M. Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat. J Tromb Trombolysis. 2008;26(2):113-118.
150. Xie J, Briggs JA, Briggs RC. Human hematopoietic cell specifc nuclear protein MNDA interacts with the multifunctional transcription factor YY1 and stimulates YY1 DNA binding. J Cell Biochem. 1998;70(4):489-506.
151. Huerta-Yepez S, Vega M, Escoto-Chavez SE, Murdock B, Sakai T, Baritaki S, et al. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1. Nitric Oxide. 2009;20(1):39-52.
152. Hongo F, Garban H, Huerta-Yepez S, Vega M, Jazirehi AR, Mizutani Y, et al. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation. Biochem Biophys Res Commun. 2005;336(2):692-701.
153. Porichis F, Morou A, Baritaki S, Spandidos DA, Krambovitis E. Activation-induced cell death signalling in CD4+ T cells by staphylococcal enterotoxin A. Toxicol Lett. 2008;176(1):77-84.
154. Baritaki S, Huerta-Yepez S, Sakai T, Spandidos DA, Bonavida B. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1. Mol Cancer Ter. 2007;6(4):1387-1399.
155. Vega MI, Baritaki S, Huerta-Yepez S, Martinez-Paniagua MA, Bonavida B. A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells. Leuk Lymphoma. 2011;52(1):108-121.
156. Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, et al. Systematic proteome analysis identifes transcription factor YY1 as a direct target of miR-34a. J Proteome Res. 2011;10(2):479-487.
157. Kaller M, Lifers S T, Oeljeklaus S, Kuhlmann K, Roh S, Hofmann R, et al. Genome-wide characterization of miR-34a Induced changes in protein and mRNA expression by a Combined pulsed SILAC and microarray analysis. Mol Cell Proteomics. 2011;10(8): M111.010462.
158. Hermeking H. Te miR-34 family in cancer and apoptosis. Cell Death Difer. 2010;17(2):193-199.
159. Nguyen N, Zhang X, Olashaw N, Seto E. Molecular cloning and functional characterization of the transcription factor YY2. J Biol Chem. 2004;15:15.
160. Kim JD, Faulk C, Kim J. Retroposition and evolution of the DNA-binding motifs of YY1, YY2 and REX1. Nucleic Acids Res. 2007;35(10):3442-3452.
161. Luo C, Lu X, Stubbs L, Kim J. Rapid evolution of a recently retroposed transcription factor YY2 in mammalian genomes. Genomics. 2006;87(3):348-355.
162. Chen L, Shioda T, Coser KR, Lynch MC, Yang C, Schmidt EV. Genome-wide analysis of YY2 versus YY1 target genes. Nucleic Acids Res. 2010;38(12):4011-4026.
163. Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, Russo AE, et al. Te involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle. 2009;8(9):1367-1372.
164. Zaravinos A, Spandidos DA. Yin yang 1 expression in human tumors. Cell Cycle. 2010;9(3):512-522.
165. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A, et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol. 2005;27(1):131-141.
166. Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, Lee P, et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res. 2005;11(10):3686-3696.
167. Baritaki S, Chatzinikola AM, Vakis AF, Soulitzis N, Karabetsos DA, Neonakis I, et al. YY1 over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels. Cancer Invest. 2009;27(2):184-192.
168. Erkeland SJ, Valkhof M, Heijmans-Antonissen C, Delwel R, Valk PJ, Hermans MH, et al. Te gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic diferentiation. Blood. 2003;101(3):1111-1117.
169. de Nigris F, Botti C, de Chiara A, Rossiello R, Apice G, Fazioli F, et al. Expression of transcription factor Yin Yang 1 in human osteosarcomas. Eur J Cancer. 2006;42(15):2420-2424.
170. de Nigris F, Botti C, Rossiello R, Crimi E, Sica V, Napoli C. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene. 2007;26:382-394.
171. Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufa G, Bonavida B, et al. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol. 2007;31(1):69-79.
172. Shin E, Lee KB, Park SY, Kim SH, Ryu HS, Park YN, et al. Gene expression profling of human hepatoblastoma using archived formalin-fixed and parafn-embedded tissues. Virchows Arch. 2011;458(4):453-465.
173. Tomassen M, Tan Q, Kruse TA. Gene expression meta-analysis identifes metastatic pathways and transcription factors in breast cancer. BMC Cancer. 2008;8:394.
174. Powe DG, Akhtar G, Habashy HO, Abdel-Fatah T, Rakha EA, Green AR, et al. Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplifcation. Breast Cancer Res. 2009;11(6):R90.
175. de Nigris F, Rossiello R, Schiano C, Arra C, Williams-Ignarro S, Barbieri A, et al. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. Cancer Res. 2008;68(6):1797-1808.
176. Matsumura N, Huang Z, Baba T, Lee PS, Barnett JC, Mori S, et al. Yin yang 1 modulates taxane response in epithelial ovarian cancer. Mol Cancer Res. 2009;7(2):210-220.
177. Castellano G, Torrisi E, Ligresti G, Nicoletti F, Malaponte G, Traval S, et al. Yin Yang 1 overexpres-sion in difuse large B-cell lymphoma is associated with B-cell transformation and tumor progression. Cell Cycle. 2010;9(3):557-563.
178. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplifed in cancer. EMBO J. 2003;22(20):5323-5335.
179. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res. 2008;647(1-2):21-29.
180. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, et al. Te polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624-629.
181. Berezovska OP, Glinskii AB, Yang Z, Li XM, Hof-man RM, Glinsky GV. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle. 2006;5(16):1886-1901.
182. Bonavida B, Huerta-Yepez S, Goodglick L, Mizutani Y, Miki T. Can we develop biomarkers that predict response of cancer patients to immunotherapy? Biomarkers. 2005;10 Suppl 1:69-76.
183. Vega MI, Huerta-Yepez S, Jazirehi AR, Garban H, Bonavida B. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. Oncogene. 2005;24(55):8114-8127.
184. Dalle S, Dupire S, Brunet-Manquat S, Reslan L, Plesa A, Dumontet C. In vivo model of follicular lymphoma resistant to rituximab. Clin Cancer Res. 2009;15(3):851-857.
185. Donia M, Maksimovic-Ivanic D, Mijatovic S, Mojic M, Miljkovic D, Timotijevic G, et al. In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells. Cell Cycle. 2011;10(3):492-499.
186. Hsu KW, Hsieh RH, Lee YH, Chao CH, Wu KJ, Tseng MJ, et al. Te activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity. Mol Cell Biol. 2008;28(15):4829-4842.
187. Natesan S, Gilman MZ. DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev. 1993;7(12B):2497-2509.
188. Li WW, Hsiung Y, Zhou Y, Roy B, Lee AS. Induction of the mammalian GRP78/BiP gene by Ca2+ depletion and formation of aberrant proteins: activation of the conserved stress-inducible grp core promoter element by the human nuclear factor YY1. Mol Cell Biol. 1997;17(1):54-60.
189. Di C, Liao S, Adamson DC, Parrett TJ, Broder-ick DK, Shi Q, et al. Identifcation of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res. 2005;65(3):919-924.
190. Satoh K, Ginsburg E, Vonderhaar BK. Msx-1 and Msx-2 in mammary gland development. J Mammary Gland Biol Neoplasia. 2004;9(2):195-205.
191. Hehlgans T, Strominger JL. Activation of transcription by binding of NF-E1 (YY1) to a newly identifed element in the frst exon of the human DR alpha gene. J Immunol. 1995;154(10):5181-5187.
192. Rangel LB, Agarwal R, Sherman-Baust CA, Mello-Coelho V, Pizer ES, Ji H, et al. Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers. Cancer Biol Ter. 2004;3(10):1021-1027.
193. Brule S, Sayasith K, Sirois J, Silversides DW, Lussier JG. Structure of the bovine VASAP-60/PRKCSH gene, functional analysis of the promoter, and gene expression analysis. Gene. 2007;391(1-2):63-75.
194. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med. 1998;158(6):1958-1962.
195. de Souza AP, Trevilatto PC, Scarel-Caminaga RM, de Brito RB, Line SR. Analysis of the TGF-beta1 promoter polymorphism (C-509T) in patients with chronic periodontitis. J Clin Periodontol. 2003;30(6):519-523.
196. Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, et al. Te transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene. 2005;24(25):4081-4093.
197. Kim JD, Yu S, Choo JH, Kim J. Two evolutionarily conserved sequence elements for Peg3/Usp29 transcription. BMC Mol Biol. 2008;9:108.
198. Abbondanza C, de Nigris F, De Rosa C, Rossiello R, Puca GA, Napoli C. Silencing of YY1 down-regulates RIZ1 promoter in human osteosarcoma. Oncol Res. 2008;17(1):33-41.
199. Bheda A, Creek KE, Pirisi L. Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes. Oncogene. 2008;27(31):4315-4323.
200. Lieberthal JG, Kaminsky M, Parkhurst CN, Tanese N. Te role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells. Breast Cancer Res. 2009;11(3):R42.
201. Becker KG, Swergold GD, Ozato K, Tayer RE. Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element. Hum Mol Genet. 1993;2(10):1697-1702.
202. Singer MF, Krek V, McMillan JP, Swergold GD, Tayer RE. LINE-1: a human transposable element. Gene. 1993;135(1-2):183-188.
203. Athanikar JN, Badge RM, Moran JV. A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res. 2004;32(13):3846-3855.
204. Mirghomizadeh F, Bullwinkel J, Orinska Z, Janssen O, Petersen A, Singh PB, et al. Transcriptional regulation of mouse mast cell protease-2 by interleukin-15. J Biol Chem. 2009;284(47):32635-32641.
205. Berndt JA, Kim JG, Tosic M, Kim C, Hudson LD. The transcriptional regulator Yin Yang 1 activates the myelin PLP gene. J Neurochem. 2001;77(3):935-942.
206. Buescher JL, Martinez LB, Sato S, Okuyama S, Ikezu T. YY1 and FoxD3 regulate antiretroviral zinc fnger protein OTK18 promoter activation induced by HIV-1 infection. J Neuroimmune Pharmacol. 2009;4(1):103-415.
207. Tone Y, Kojima Y, Furuuchi K, Brady M, Yashiro-Ohtani Y, Tykocinski ML, et al. OX40 Gene Expression Is Up-Regulated by Chromatin Remodeling in Its Promoter Region Containing Sp1/Sp3, YY1, and NF-{kappa}B Binding Sites. J Immunol. 2007;179(3):1760-1767.
208. Redmond WL, Weinberg AD. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer. Critical reviews in immunology. 2007;27(5):415-436.
209. Oei SL, Shi Y. Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair. Biochem Biophys Res Commun. 2001;284(2):450-454.
210. Labrie C, Lee BH, Mathews MB. Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. Nucleic Acids Res. 1995;23(18):3732-3741.
211. Jiang L, Yao M, Shi J, Shen P, Niu G, Fei J. Yin yang 1 directly regulates the transcription of RE-1 silencing transcription factor. J Neurosci Res. 2008;86(6):1209-1216.
212. Majumder S. REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle. 2006;5(17):1929-1935.
213. Jacobsen BM, Skalnik DG. YY1 binds fve cis-elements and trans-activates the myeloid cell-restricted gp91(phox) promoter. J Biol Chem. 1999;274(42):29984-93.
214. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008;266(1):37-52.
215. Glenn DJ, Wang F, Chen S, Nishimoto M, Gardner DG. Endothelin-stimulated human B-type natri-uretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2. Hypertension. 2009;53(3):549-555.
216. Holloway K, Sade H, Romero IA, Male D. Action of transcription factors in the control of transferrin receptor expression in human brain endothelium. J Mol Biol. 2007;365(5):1271-1284.
217. Yokoyama NN, Pate KT, Sprowl S, Waterman ML. A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer. Nucleic Acids Res. 2010;38(19):6375-6388.
218. Klar M, Bode J. Enhanceosome formation over the beta interferon promoter underlies a remote-control mechanism mediated by YY1 and YY2. Mol Cell Biol. 2005;25(22):10159-10170.
219. Miao J, Wang Z, Provencher H, Muir B, Dahiya S, Carney E, et al. HOXB13 promotes ovarian cancer progression. Proc Natl Acad Sci U S A. 2007;104(43):17093-17098.
220. Teng CF, Wu HC, Tsai HW, Shiah HS, Huang W, Su IJ. Novel feedback inhibition of surface antigen synthesis by Mammalian Target of Rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy. Hepatology. 2011;54:1199-11207.
221. Meyer KB, Maia AT, O'Reilly M, Ghoussaini M, Prathalingam R, Porter-Gill P, et al. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genet. 2011;7(7):e1002165.
222. Liu Q, Merkler KA, Zhang X, McLean MP. Pros-taglandin F2alpha suppresses rat steroidogenic acute regulatory protein expression via induction of Yin Yang 1 protein and recruitment of histone deacetylase 1 protein. Endocrinology. 2007;148(11):5209-5219.
223. Kim HJ, Kim JE, Ha M, Kang SS, Kim J T, Park IS, et al. Steroidogenic acute regulatory protein expression in the normal human brain and intracranial tumors. Brain Res. 2003;978(1-2):245-249.
224. Franchina M, Woo AJ, Dods J, Karimi M, Ho D, Watanabe T, et al. Te CD30 gene promoter micro-satellite binds transcription factor Yin Yang 1 (YY1) and shows genetic instability in anaplastic large cell lymphoma. J Pathol. 2008;214(1):65-74.
225. Lee BC, Lee TH, Zagozdzon R, Avraham S, Usheva A, Avraham HK. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration. Cancer Res. 2005;65(7):2840-2845.
226. Tarnowski M, Grymula K, Reca R, Jankowski K, Maksym R, Tarnowska J, et al. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol Cancer Res. 2010;8(1):1-14.
227. He CQ, Ding NZ, Fan W. YY1 repressing peroxi-some proliferator-activated receptor delta promoter. Mol Cell Biochem. 2008;308(1-2):247-252.
228. Crawford EL, Blomquist T, Mullins DN, Yoon Y, Hernandez DR, Al-Bagdhadi M, et al. CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modifed by E2F1/YY1 interactions. Carcinogenesis. 2007;28(12):2552-2559.
229. Cicatiello L, Addeo R, Sasso A, Altucci L, Petrizzi VB, Borgo R, et al. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol. 2004;24(16):7260-7274.
230. Lopez-Bayghen E, Vega A, Cadena A, Granados SE, Jave LF, Gariglio P, et al. Transcriptional analysis of the 5'-noncoding region of the human involucrin gene. J Biol Chem. 1996;271(1):512-20.
231. Xu X, Kawachi Y, Nakamura Y, Sakurai H, Hirota A, Banno T, et al. Yin-yang 1 negatively regulates the diferentiation-specifc transcription of mouse loricrin gene in undiferentiated keratinocytes. J Invest Dermatol. 2004;123(6):1120-1126.
232. Alvarez-Salas LM, Benitez-Hess ML, Dipaolo JA. YY-1 and c-Jun transcription factors participate in the repression of the human involucrin promoter. Int J Oncol. 2005;26(1):259-266.
233. Kobrossy L, Rastegar M, Featherstone M. Interplay between chromatin and trans-acting factors regulating the Hoxd4 promoter during neural diferentia-tion. J Biol Chem. 2006;281(36):25926-25939.
234. Yang WM, Yao YL, Sun JM, Davie JR, Seto E. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J Biol Chem. 1997;272(44):28001-28007.
235. Sucharov CC, Langer S, Bristow M, Leinwand L. Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A. Am J Physiol Cell Physiol. 2006;291(5):C1029-C1037.
236. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D. Diferent EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell. 2004;14(2):183-193.
237. Donohoe ME, Zhang LF, Xu N, Shi Y, Lee J T. Identification of a ctcf cofactor, yy1, for the x chromosome binary switch. Mol Cell. 2007;25(1):43-56.
238. Filippova GN. Genetics and epigenetics of the multifunctional protein CTCF. Cur Top Dev Biol. 2008;80:337-360.
239. Liao WR, Hsieh RH, Hsu KW, Wu MZ, Tseng MJ, Mai RT, et al. Te CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1. Carcinogen-esis. 2007;28(9):1867-1876.
240. Shrivastava A, Saleque S, Kalpana GV, Artandi S, Gof SP, Calame K. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science. 1993;262(5141):1889-1892.
241. Inayoshi Y, Okino Y, Miyake K, Mizutani A, Yama-moto-Kishikawa J, Kinoshita Y, et al. Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes. J Virol. 2010;84(16):8250-8261.
242. Yeh TS, Lin YM, Hsieh RH, Tseng MJ. Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch. J Biol Chem. 2003;278(43):41963-41969.
243. Kuzmin A, Han Z, Golding MC, Mann MR, Latham KE, Varmuza S. Te PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues. Gene Expr Patterns. 2008;8(2):107-116.
244. Ohtomo T, Horii T, Nomizu M, Suga T, Yamada J. Molecular cloning of a structural homolog of YY1AP, a coactivator of the multifunctional transcription factor YY1. Amino Acids. 2007;33(4):645-452.
245. Wang CY, Liang YJ, Lin YS, Shih HM, Jou YS, Yu WC. YY1AP, a novel co-activator of YY1. J Biol Chem. 2004;279(17):17750-17755.
246. Li L, Shi Y, Wu H, Wan B, Li P, Zhou L, et al. Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2. Mol Cell Biochem. 2007;304(1-2):297-304.
247. Kalenik JL, Chen D, Bradley ME, Chen SJ, Lee TC. Yeast two-hybrid cloning of a novel zinc fnger protein that interacts with the multifunctional transcription factor YY1. Nucleic Acids Res. 1997;25(4):843-9.
248. Bannasch D, Madge B, Schwab M. Functional interaction of Yaf2 with the central region of MycN. Oncogene. 2001;20(41):5913-5919.
249. Huang WH, Mai RT, Lee YH. Transcription factor YY1 and its associated acetyltransferases CBP and p300 interact with hepatitis delta antigens and modulate hepatitis delta virus RNA replication. J Virol. 2008;82(15):7313-7324.
250. Kang HC, Chung BM, Chae JH, Yang SI, Kim CG, Kim CG. Identifcation and characterization of four novel peptide motifs that recognize distinct regions of the transcription factor CP2. FEBS J. 2005;272(5):1265-1277.
251. Lee KH, Evans S, Ruan TY, Lassar AB. SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specifc expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer. Development. 2004;131(19):4709-4723.
252. Ralph WM Jr, Liu K, Auborn KJ. CCAAT/ enhancer-binding protein beta represses human papillomavirus 11 upstream regulatory region expression through a promoter-proximal YY1-binding site. J Gen Virol. 2006;87(Pt 1):51-59.
253. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008;18(4):452-457.
254. Beck K, Wu BJ, Ni J, Santiago FS, Malabanan KP, Li C, et al. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia. Circ Res. 2010;107(12):1490-1497.